文献速递甲状腺疾病

融合癌基因是儿童散发性甲状腺乳头状癌的主要遗传事件

Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
PubMed 文献 · Thyroid · 2016-12-27

该研究对35例以散发性为主的儿童甲状腺乳头状癌(PTC)进行筛查,检测RET/PTC1、RET/PTC2、RET/PTC3、ETV6-NTRK3、AGK-BRAF融合及BRAFV600E、NRASQ61点突变。20例(57%)发现突变,融合癌基因为主要遗传改变;BRAFV600E与年龄较大及肿瘤较大相关,RET/PTC3与肿瘤较大及多灶性相关。作者结论认为该队列遗传特征与成人显著不同,但与辐射暴露儿童PTC的突变谱相似。

要点

  • 35例儿童PTC中20例(57%)检出突变,融合癌基因为主要遗传改变。
  • RET/PTC1-3重排见于13例(37%),ETV6-NTRK3 3例(9%),AGK-BRAF 4例(11%),BRAFV600E 3例(9%)。
  • BRAFV600E与年龄较大及肿瘤较大相关(p < 0.05),RET/PTC3与肿瘤较大及多灶性相关(p < 0.05)。

核心结论

  • 该队列的遗传特征与成人PTC显著不同,但与辐射暴露儿童PTC的突变谱相似,尽管检出率较低。
  • 超过40%的PTC病例未发现突变,作者认为需在这些患者中开展更全面的研究以阐明散发性儿童PTC的遗传图谱。

研究设计与样本

  • 研究对35例以散发性为主的儿童甲状腺乳头状癌(PTC)进行筛查,检测RET/PTC1、RET/PTC2、RET/PTC3、ETV6-NTRK3、AGK-BRAF融合及BRAFV600E、NRASQ61点突变,并将突变状态与临床病理数据关联。

主要发现

  • 35例PTC中20例(57%)发现突变。
  • RET/PTC1-3重排见于13例(37%),ETV6-NTRK3见于3例(9%),AGK-BRAF见于4例(11%),BRAFV600E见于3例(9%),NRASQ61未发现突变。
  • BRAFV600E与年龄较大及肿瘤较大相关(p < 0.05)。
  • RET/PTC3与肿瘤较大及多灶性相关(p < 0.05)。

关键数值与推荐

  • RET/PTC1-3重排:13/35(37%)。
  • ETV6-NTRK3:3/35(9%)。
  • AGK-BRAF:4/35(11%)。
  • BRAFV600E:3/35(9%)。
  • NRASQ61:0/35。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies reported significant differences in the clinical presentation and outcomes of papillary thyroid carcinoma (PTC) in pediatric patients compared with adults. Previous studies have suggested that the clinicopathological differences observed between pediatric and adult PTCs may be due the existence of distinct genetic alterations. However, the knowledge of genetic events in pediatric PTCs is based primarily on studies in radiation-exposed PTCs or in the few studies that enrolled predominantly adolescent patients. The aim of this study was to characterize the known oncogenic alterations of the MAPK pathway found in adult and radiation-exposed PTCs in a cohort of predominantly sporadic pediatric PTC patients. METHODS: Thirty-five pediatric PTCs were screened for the most prevalent fusions (RET/PTC1, RET/PTC2, RET/PTC3, ETV6-NTRK3, and AGK-BRAF) and point mutations (BRAFV600E and NRASQ61) described in sporadic pediatric PTCs. The mutational status was correlated with clinicopathological data. RESULTS: Mutations were found in 20 out of 35 (57%) PTC cases. Fusion oncogenes were the main genetic alterations found. RET/PTC1-3 rearrangements were found in 13 (37%), ETV6-NTRK3 in 3 (9%), AGK-BRAF in 4 (11%), and BRAFV600E in 3 (9%). No mutation was found in NRASQ61. BRAFV600E was associated with older age and larger tumor size (p < 0.05), and RET/PTC3 was associated with a larger tumor size and multifocality (p < 0.05). CONCLUSIONS: The genetic signature in this cohort was remarkably different than that observed in adults. Although observed at a lower prevalence, the spectrum of mutations was quite similar to that described in radiation-exposed pediatric PTCs. As mutations were unidentifiable in over 40% of the PTC cases, more comprehensive studies conducted in these patients will help to decipher the genetic landscape of sporadic pediatric PTCs.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Cordioli MI, Moraes L, Bastos AU, et al. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children. Thyroid. 2016. PMID: 27849443. doi:10.1089/thy.2016.0387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。